{"id":863,"date":"2012-07-03T23:30:20","date_gmt":"2012-07-03T23:30:20","guid":{"rendered":"http:\/\/ctcps.org\/blog\/?p=863"},"modified":"2013-01-22T18:05:40","modified_gmt":"2013-01-22T18:05:40","slug":"glaxosmithkline-settles-healthcare-fraud-case-for-3-billion","status":"publish","type":"post","link":"https:\/\/blog.ctcps.org\/?p=863","title":{"rendered":"GlaxoSmithKline settles healthcare fraud case for $3 billion"},"content":{"rendered":"<p>By David Ingram | Reuters \u2013 Mon, Jul 2, 2012 | WASHINGTON (Reuters) &#8211; GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials on Monday described as the largest case of healthcare fraud in U.S. history.<br \/>\nThe agreement, which still needs court approval, would resolve allegations that the British drugmaker broke U.S. laws in the marketing and development of pharmaceuticals.\u00a0 <a href=\"http:\/\/news.yahoo.com\/glaxosmithkline-settles-fraud-charges-3-billion-144748923--finance.html\">Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>By David Ingram | Reuters \u2013 Mon, Jul 2, 2012 | WASHINGTON (Reuters) &#8211; GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle <\/p>\n<p class=\"readMore\"><a class=\"read-more\" href=\"https:\/\/blog.ctcps.org\/?p=863\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4,6],"tags":[347,343,344,345,213,42,346],"class_list":["post-863","post","type-post","status-publish","format-standard","hentry","category-showcase","category-newsroom","tag-avandia","tag-glaxosmithkline","tag-healthcare-fraud","tag-paxil","tag-pharmaceutical-fraud","tag-pharmaceuticals","tag-wellbutrin"],"_links":{"self":[{"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=\/wp\/v2\/posts\/863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=863"}],"version-history":[{"count":2,"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=\/wp\/v2\/posts\/863\/revisions"}],"predecessor-version":[{"id":1161,"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=\/wp\/v2\/posts\/863\/revisions\/1161"}],"wp:attachment":[{"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}